Epicore Biosystems key facts
as of Oct 2026- Developer of a wearable microfluidic sensor technology designed to improve health and drive athletic performance.
- Epicore Biosystems is valued at approximately $121.0M as of Oct 2026, set at its later-stage round, May 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $43.1M across 4 recorded rounds; the latest was Early Stage VC ($25.7M) in Dec 2024.
- Notable investors include Alumni Ventures, Joyance Partners, Pegasus Tech Ventures, Reform Ventures, Chevron Technology Ventures — 13 tracked in total.
- Epicore Biosystems has filed 6 Form Ds with the SEC since 2018, most recently Apr 2025 ($25.7M sold to 4 investors).
- Status: Privately Held (backing).
Valued at $121.0M at its later-stage round, May 2025. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch Epicore Biosystems: the Monday email on marks, rounds and moves
Epicore Biosystems funding rounds
4 roundsWho backs Epicore Biosystems
13+Epicore Biosystems valuation
Epicore Biosystems was valued at $121 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Epicore Biosystems raised?
Epicore Biosystems has raised $43.1 million across 4 recorded rounds since 2018. The largest was a $9.5 million early-stage round in Nov 2021; the most recent was a $25.7 million early-stage round in Dec 2024.
Epicore Biosystems has filed 6 Form Ds with the SEC since 2018, most recently in Apr 2025 ($25.7 million sold to 4 investors).
Epicore Biosystems investors
13 investors are on record for Epicore Biosystems, including Alumni Ventures, Joyance Partners, Pegasus Tech Ventures and Reform Ventures. By type, the record holds 5 venture capital firms. The early-stage round in Dec 2024 drew 4 investors.
About Epicore Biosystems
Developer of a wearable microfluidic sensor technology designed to improve health and drive athletic performance. The company's sensors can non-invasively measure sweat biomarkers, skin health and physiology in real-time, enabling athletes to analyze small droplets of sweat directly from their skin at a low cost.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2017
- Employees
- 35
- Website
- epicorebiosystems.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.